Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

A NOVEL NON-INVASIVE DNA METHYLATION TEST FOR MELANOMA

Project description

Non-invasive DNA methylation panel for melanoma detection

The survival rate for melanoma declines sharply from over 98 % at Stage 1 to approximately 22 % at Stage 4. Currently, diagnosis relies on visual inspection and biopsy with histopathology, which is costly and invasive. Many cases turn out to be benign, indicating avoidable invasive procedures and the need for better triage. The EIC-funded MitraTest project is developing a non-invasive tape-strip skin sampling technique combined with a proprietary DNA methylation molecular test for melanoma detection. This innovation will enable efficient, affordable testing in primary care and at-home settings. A proof-of-concept study demonstrated over 95 % specificity and 85 % sensitivity compared to standard biopsy and histopathology. MitraTest aims to improve melanoma detection and reduce its health and economic burden.

Objective

Early cancer detection is a key to improve survival rates. For melanoma the survival falls from >98% at Stage 1 to 22% at Stage 4.
Currently, skin biopsy is the only method of melanoma detection. It is an expensive and invasive procedure. Our patented technology, is a combination of a unique non-invasive tape strip skin sample collection technique and proprietary DNA methylation panel specific for melanoma. This will allow quick and inexpensive testing for melanoma at GP level and as an at-home test kit.
Our proof of concept study with Guy’s Hospital (UK) showed over 95% specificity and 85% sensitivity in detecting melanoma compared to standard biopsy procedures.
Mitra Bio is a female-led team of 6 scientists and business developers with experience in building diagnostics platforms. We aim to improve melanoma detection and reduce melanoma health and economic burden, which currently results in 15K deaths/year in the EU.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC - HORIZON EIC Accelerator

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2025-ACCELERATOR-02

See all projects funded under this call

Coordinator

MITRA BIO LIMITED
Net EU contribution
€ 2 499 000,00
Address
CENTRAL WORKING WHITE CITY TRANSLATION AND INNOVATION HUB 84 WOOD LANE
W12 0BZ LONDON
United Kingdom
SME
Yes
Region
London Inner London — West Kensington & Chelsea and Hammersmith & Fulham
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data